Skip to main content
. 2022 Dec 15;14(12):2808. doi: 10.3390/pharmaceutics14122808

Figure 3.

Figure 3

Timeline from 1995 to 2021 concerning representative anticancer pharmaceuticals loaded in nanoparticles approved by the American Food and Drug Administration for clinical purposes.